Takeda partners with Twist Bioscience to expand biologics discovery capabilities
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research
Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
The arrangement aims to supply Nanalysis 60 and 100 MHz benchtop NMR spectrometer purchasers with ACD/Spectrus Processor software for data processing and analysis
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
First subjects recently administered immunizations in two studies of 20-valent pneumococcal conjugate vaccine candidate in infants; a pentavalent meningococcal vaccine candidate in adolescents; and a respiratory syncytial virus vaccine candidate in pregnant women
Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019
The collaboration also includes the University of Coventry, UCB, and is supported by EIT Digital.
Our new expert webinar series aims to help you get the most from your microbiology research
The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs
These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season
Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology
The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19
It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers